KAN571（Kancera AB）

N/A

Report date: 2023/05/05 18:02:46
NME

Base Information

Drug NameKAN571（Kancera AB）
Drug Alias NameKAN-571KAN571
ClassificationSmall molecules
Mechanisms of ActionInactive tyrosine-protein kinase transmembrane receptor ROR1 antagonistsApoptosis stimulants
TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1
Therapy Area/IndicationsLymphoma, Mantle-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsLymphoma, Mantle-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A